Screen2Prevent (S2P)
ConditionHIV Infections
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14-24
SponsorWestat
About this trial
Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digital health to identify and link adolescents seeking care in the ED to HIV Pre-Exposure Prophylaxis (PrEP)/Antiretroviral treatment (ART).
Eligibility criteria
Qualifiers
Age 14-24 years, inclusive
Present to the participating ED, regardless of chief complaint during the study period
Disqualifiers
None
Trial design
Treatments tested in this trial
- HIV screening strategies
Treatment groups
84,000 Participants
are divided into 6 treatment groups6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Source ClinicalTrials.gov